Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.

Abedi, Farshad

Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. [electronic resource] - Ophthalmology Aug 2013 - 1641-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1549-4713

10.1016/j.ophtha.2013.01.014 doi


Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Bevacizumab
Cohort Studies
Complement C3b Inactivator Proteins--genetics
Complement Factor H--genetics
Complement System Proteins--genetics
Female
Genotype
High-Temperature Requirement A Serine Peptidase 1
Humans
Male
Middle Aged
Pharmacogenetics
Polymorphism, Single Nucleotide
Prospective Studies
Proteins--genetics
Ranibizumab
Retreatment
Serine Endopeptidases--genetics
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Visual Acuity--physiology
Wet Macular Degeneration--drug therapy